How Multipurpose is a Disposable Bioreactor? - The authors discuss the use of single-use bioreactors throughout industry. - BioPharm International

ADVERTISEMENT

How Multipurpose is a Disposable Bioreactor?
The authors discuss the use of single-use bioreactors throughout industry.


BioPharm International
Volume 24, Issue 3, pp. 51-56

CONCLUSION

Single-use bioreactors have become accepted by industry and academic laboratories because of ease of use, flexibility, cost of operation, and lower investments. The CELL-tainer single-use bioreactor system can be used in a wide variety of applications: intensive cell cultures, fragile cultivation systems like with micro-carriers and hybridoma cultures, and also in microbial fermentations (e.g. yeast and fungal cultures) due to its ability to deliver proper mixing and high mass transfer. Because the system is equipped with advanced process control, which could include in-line analysis of glucose and lactate, the CELL-tainer widens the application of single-use bioreactors even to traditional biotechnology processes as a process development tool or as pre-culture system.

ACKNOWLEDGMENT

The authors would like to thank Nick van Biezen and Jeroen Schouwenberg (HAN Biocenter, Nijmegen, The Netherlands) and Anton Tromper (CELLution Biotech) for their contribution in the E.coli cultivation work.

Dr. Nico M.G. Oosterhuis is CTO/CSO at CeLLution Biotech, Assen, The Netherlands (
). Hans J. van den Berg is an independent business developer.

REFERENCES

1. V. Singh, Disposable bioreactor for cell culture using wave-induced agitation, Cytotechnology, 30: 149-158 (1999).

2. J. Simola, Characterization of WAVE Bioreactor to scale-up mAb cell culture process from 10L to 100L, Esact Conference Proceedings, 2009.

3. R. Eibl, D. Eibl. "Design and use of the Wave Bioreactor for plant cell culture," in Plant Tissue Culture Engineering, G.S. Dutta and Y. Ibaraki, Eds. (Springer, New York, NY, 2006).

4. P. Van der Heiden, M. Buevink, N.M.G. Oosterhuis WO 2007/001173 A2 (2007).

5. L.L. Weng, Strategies for accelerated development of microbial fermentation processes (Boston, November 2009).


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines
Source: BioPharm International,
Click here